Financial insights of PFE

MyFinsight

For the year ending 2025-12-31, PFE made $62,579M in revenue. $7,771M in net income. Net profit margin of 12.42%.

Income Statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total revenues	62,579	63,627	58,496	100,330
Cost of sales	16,067	17,851	24,954	34,344
Selling, informational and administrative expenses	13,794	14,730	14,771	13,677
Research and development expenses	10,437	10,822	10,679	11,428
Acquired in-process research and development expenses	1,613	108	194	953
Amortization of intangible assets	4,874	5,286	4,733	3,609
Restructuring charges and certain acquisition-related costs	1,550	2,419	2,943	1,375
Other (income)/deductionsnet	-6,724	-4,388	835	-217
Income from continuing operations before provision/(benefit) for taxes on income	7,520	8,023	1,058	34,729
Provision/(benefit) for taxes on income	-266	-28	-1,115	3,328
Income from continuing operations	7,787	8,051	2,172	31,401
Discontinued operationsnet of tax	25	11	-15	6
Net income before allocation to noncontrolling interests	7,812	8,062	2,158	31,407
Less net income attributable to noncontrolling interests	41	31	39	35
Net income attributable to pfizer inc. common shareholders	7,771	8,031	2,119	31,372

Basic EPS	1.37	1.42	0.38	5.59
Diluted EPS	1.36	1.41	0.37	5.47
Basic Average Shares	5,683,000,000	5,664,000,000	5,643,000,000	5,608,000,000
Diluted Average Shares	5,713,000,000	5,700,000,000	5,709,000,000	5,733,000,000